View printer-friendly version
« Back
March 12, 2018 8:41 a.m.
Teva to Present at the Cowen & Company 38th Annual Healthcare Conference

JERUSALEM--(BUSINESS WIRE)--Mar. 12, 2018-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will host a live audio webcast at the Cowen & Company 38th Annual Healthcare Conference in Boston, MA.



Tuesday, March 13, 2018 at 11:20 AM ET


Michael McClellan, EVP & Chief Financial Officer
Teva Pharmaceutical Industries Ltd.




Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s Website at


About Teva

Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2017 were $22.4 billion.

Source: Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.
IR Contacts
United States
Kevin C. Mannix, 215-591-8912
Ran Meir, 215-591-3033
Tomer Amitai, 972 (3) 926 7656
PR Contacts
United States
Kaelan Hollon, 202-412-7076
Yonatan Beker, 972 (54) 888 5898